What patients are told about prescription medicines is strictly regulated in Europe. Advertising to patients is prohibited and information has to be channelled via health professionals. But these rules have become increasingly problematic, as patients become more assertive in seeking out their own information. Can a clear distinction be drawn between information and advertisement? Does the Commission's proposal contain sufficient safeguards for patients? Who stands to benefit - patients, the drugs industry, or healthcare professionals? Read more...

24-25 February 2010

This EAPB Conference aims to promote partnership between academic settings and industry. The goal is to enhance the economical output of scientific research and direct them into marketable technologies and biopharmaceutical products. Read more...

2-3 March 2010

This 2nd African Regulatory Conference will focus on access to safe, effective, quality and affordable medicines in the Region. It will offer the opportunity to foster collaboration between African Regulatory Authorities and the pharmaceutical industry, share information and best practices and identify potential workable solutions which meet the needs of the Region. Read more...

2-3 March 2010

This Market Access Europe Summit brings together a top selection of pharmaceutical specialists and experienced professionals to share their knowledge, their views and give you insight into how they are dealing with the challenges and opportunities in the changing pharmaceutical landscape and impending healthcare reforms. Read more...

29-30 March 2010

The pharmaceutical/biotech/medical device industry is undergoing significant transformations and the need for meaningful and cost-effective communications is greater than ever. Changes in the political, economic and regulatory environments coupled with revolutions in technology are creating an exciting, yet challening, atmosphere in which companies must operate. This conference will provide industry professionals with concrete tools for enhancing both internal and external communications, through sessions covering a broad range of topics including social media, the industry's reputation, working effectively with the media and much more. Read more...

15-16 April 2010

The conference will offer an overview of the latest innovations in European legislative activity and the most important recent case law and pending judgments of the Community Courts affecting the pharmaceutical sector. Read more...

19-23 April 2010

The INSEAD Healthcare Compliance Leadership Programme is jointly developed by INSEAD and senior compliance executives of leading healthcare companies and associations. The 2010 programme assumes that compliance executives, in addition to "technical" compliance expertise, need leadership skills that allow them to influence individuals and organizations. Its key objective is to develop the leadership competencies necessary to bring about effective compliance in healthcare companies. Read more...

21-23 June 2010

Annual meetings programme as well as further information will be available soon.

22 June 2010

The further development of EudraVigilance supporting the EU pharmacovigilance and risk management strategy remains one of the priorities of the EMEA’s work programme. This event will provide a forum for marketing authorisation holders and sponsors of clinical trials to gain an update on the key activities of the EV-EWG in line with their work programme for 2010. Read more...

17-23 July 2010

For this Congress, basic and clinical pharmacology will come together to encompass the whole process of drug development from molecular biology to clinical practice. The world’s basic and clinical pharmacologists and all those dealing with the development and use of drugs will meet to discuss how a collaborative work approach can be established to accommodate the need for safe and effective medicines at affordable prices. Read more...

14-15 October 2010

Medicines need to be safe, effective and of good quality. The EDQM contributes to this goal by establishing and providing standards, which apply to the manufacture and quality control of medicines in all the signatory states of the Convention for the elaboration of a European Pharmacopoeia and beyond. Providing good quality medicines or active pharmaceutical ingredients (APIs) is a global concern. This conference will bring together regulators, industry and trade associations and key stakeholders from around the world to discuss the challenges and issues surrounding the quality of medicines in a globalised world. Read more...